164 related articles for article (PubMed ID: 7660358)
1. Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model.
Fu K; Izquierdo R; Walenga JM; Fareed J
Thromb Res; 1995 Jun; 78(5):421-8. PubMed ID: 7660358
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the antithrombotic effect of the new recombinant hirudin HBW 023 and heparin in small arteries and veins.
Zhang B; Wieslander JB
Microsurgery; 1996; 17(2):89-96. PubMed ID: 8914063
[TBL] [Abstract][Full Text] [Related]
3. Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model.
Fu K; Izquierdo R; Vandevender D; Warpeha RL; Wolf H; Fareed J
Thromb Res; 1997 Jun; 86(5):355-61. PubMed ID: 9211626
[TBL] [Abstract][Full Text] [Related]
4. Prevention of microvascular thrombosis by topical application of recombinant tissue factor pathway inhibitor.
Lantieri LA; Ozbek MR; Deune EG; Ornberg RL; Brown DM; Chung SH; Wun TC; Cooley BC; Khouri RK
Plast Reconstr Surg; 1996 Mar; 97(3):587-94. PubMed ID: 8596790
[TBL] [Abstract][Full Text] [Related]
5. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma.
Khouri RK; Koudsi B; Kaiding F; Ornberg RL; Wun TC
Ann Plast Surg; 1993 May; 30(5):398-402; discussion 402-4. PubMed ID: 8342923
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic action of recombinant hirudin in a venous thrombosis model.
Raake W; Klauser RJ; Elling H; Zeiller P
Haemostasis; 1991; 21 Suppl 1():127-32. PubMed ID: 1654293
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor.
Arnljots B; Bergqvist D
Plast Reconstr Surg; 1995 Apr; 95(5):894-900. PubMed ID: 7708874
[TBL] [Abstract][Full Text] [Related]
8. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
[TBL] [Abstract][Full Text] [Related]
9. Hirudin causes more bleeding than heparin in a rabbit ear bleeding model.
Klement P; Liao P; Hirsh J; Johnston M; Weitz JI
J Lab Clin Med; 1998 Sep; 132(3):181-5. PubMed ID: 9735923
[TBL] [Abstract][Full Text] [Related]
10. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J
Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
Ching S; Thoma A; Monkman S; Kelton JG
Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
[TBL] [Abstract][Full Text] [Related]
12. Antithrombotic activity of recombinant hirudin in the rat: a comparative study with heparin.
Doutremepuich C; Deharo E; Guyot M; Lalanne MC; Walenga J; Fareed J
Thromb Res; 1989 Jun; 54(5):435-45. PubMed ID: 2772867
[TBL] [Abstract][Full Text] [Related]
13. Use of recombinant hirudin to increase the patency rate of microanastomosis in a rabbit model.
Hubbard T; Olivier T; Bacher P; Walenga JM; Galal H; Fareed J; Pifarre R
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):101-3. PubMed ID: 1772976
[TBL] [Abstract][Full Text] [Related]
14. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
15. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
[TBL] [Abstract][Full Text] [Related]
16. Effects of different hirudins and combinations of low doses of hirudin, heparin and acetylsalicylic acid in a rat microcirculatory thrombosis model.
Krupinski K; Breddin HK
Haemostasis; 1991; 21 Suppl 1():88-92. PubMed ID: 1894199
[TBL] [Abstract][Full Text] [Related]
17. An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent.
Fareed J; Walenga JM; Iyer L; Hoppensteadt D; Pifarre R
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):135-47. PubMed ID: 1772981
[TBL] [Abstract][Full Text] [Related]
18. Some objective considerations for the neutralization of the anticoagulant actions of recombinant hirudin.
Fareed J; Walenga JM; Pifarre R; Hoppensteadt D; Koza M
Haemostasis; 1991; 21 Suppl 1():64-72. PubMed ID: 1894198
[TBL] [Abstract][Full Text] [Related]
19. Effects of enoxaparin, standard heparin, and streptokinase on the patency of anastomoses in severely crushed arteries.
Chen LE; Seaber AV; Korompilias AV; Urbaniak JR
Microsurgery; 1995; 16(10):661-5. PubMed ID: 8676728
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on the antithrombotic efficacy of hirudin, heparin and a low-molecular weight heparin in preventing experimentally induced venous thrombosis.
Monreal M; Galego G; Monreal L; Angles AM; Monasterio J; Oller B
Haemostasis; 1993; 23(3):179-83. PubMed ID: 8276322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
